Serum adiponectin and leptin concentrations in patients with chronic pancreatitis of alcoholic and nonalcoholic origin

Pancreas

Volumn 36, Issue 2, 2008, Pages 120-124

  Adrych, Krystian ^a   Smoczynski, Marian ^a   Stelmanska, Ewa ^b   Korczynska, Justyna ^b   Goyke, Elzbieta ^b   Swierczynski, Julian ^b  

^a Department of Gastroenterology and Hepatology ^*  (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adiponectin; BMI; Chronic pancreatitis; Insulin; Leptin

Indexed keywords

ADIPONECTIN; FIBRONECTIN; INSULIN; LEPTIN; ADIPONECTIN, HUMAN;

ADULT; AGED; ALCOHOLIC PANCREATITIS; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADIPONECTIN; ADULT; AGED; BODY MASS INDEX; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; PANCREATITIS, ALCOHOLIC; PANCREATITIS, CHRONIC; RADIOIMMUNOASSAY;

EID: 45549096742     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181561187     Document Type: Article

References (40)

1. Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas. 1997;14:215-221.
2. Forsmark CE. Chronic pancreatitis. In: Feldman M, Friedman FS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. Philadelphia, PA: W. B. Saunders; 2002:943-969.
3. Sarles H. Definitions and classifications of pancreatitis. Pancreas. 1991;6:470-474.
4. Hackert T, Hartwig W, Friess H, et al. Acute retinopathy following pancreatic head resection for chronic pancreatitis: a rare, severe complication. JOP. 2005;6:460-463.
5. Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J Gastroenterol. 2004;99:2256-2270.
6. DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol. 2005;21:544-554.
7. Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29-33.
8. Ouchi N, Kihara S, Arita Y, et al. Novel modulator of endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473-2476.
9. Tacke F, Wustefeld T, Horn R, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol. 2005;42:666-673.
10. Kaser S, Moschen A, Kaser A, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med. 2005;258:274-280.
11. Tietge UJ, Boker KH, Manns MP, et al. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab. 2004;287:E82YE89.
12. Zoccali C, Mallamaci F, Panuccio V, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003;84:S98YS102.
13. Guebre-Egziabher F, Bernhard J, Funahashi T, et al. Adiponectin in chronic kidney disease is related more to metabolic disturbance than to decline in renal function. Nephrol Dial Transplant. 2005;20: 129-134.
14. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005; 112:1756-1762.
15. Musso G, Gambino R, Biroli G, et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with non-alcoholic steatohepatitis. Am J Gastroenterol. 2005;100:2438-2446.
16. Pelmme F, Smith U, Funahashi T, et al. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes. 2003;52:1182-1186.
17. Adrych K, Smoczynski M, Goyke E, et al. Decreased serum leptin concentration in patients with chronic pancreatitis. Pancreas. 2007;34:417-422.
18. Wolf A, Wolf D, Rumpold H, et al. Adiponectin induces the anti-inflammatory cytokines Il-10, and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630-635.
19. Otero M, Lago R, Lago F, et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 2005;579:295-301.
20. Otero M, Lago R, Gomez R, et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford). 2006;45:944-950.
21. Faggioni R, Feingold K, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 2001; 15:2565-2571.
22. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune response. FASEB J. 1998;12:57-65.
23. Konturek PC, Jaworek J, Maniatoglu A, et al. Leptin modulates the inflammatory response in acute pancreatitis. Digestion. 2002;65: 149-160.
24. Warzecha Z, Dembinski A, Ceranowicz P, et al. Influence of leptin administration on the course of acute ischemic pancreatitis. J Physiol Pharmacol. 2002;53:775-790.
25. Yavuz N, Unal E, Memisoglu K, et al. Plasma leptin levels in rats with pancreatitis. Tohoku J Exp Med. 2004;204:243-248.
26. Tukiainen E, Kylanpaa ML, Ebeling P, et al. Leptin and adiponectin levels in acute pancreatitis. Pancreas. 2006;32:211-214.
27. Duarte-Rojo A, Lezama-Barreda A, Ramirez-Iglesias T, et al. Is leptin related to systematic inflammatory response in acute pancreatitis? World J Gastroenterol. 2006;12:4392-4396.
28. Pravdova E, Fickova M. Alcohol intake modulates hormonal activity of adipose tissue. Endocr Regul. 2006;40:91-104.
29. Homma T. Criteria for pancreatitis disease diagnosis: diagnostic criteria for chronic pancreatitis. Pancreas. 1998;16:250-254.
30. Sarner M, Cotton PB. Classification of pancreatitis. Gut. 1984;25: 756-759.
31. Zabrocka L, Raczynska S, Goyke E, et al. BMI is the leptin main determinant of the circulating leptin in women after vertical banded gastroplasty. Obes Res. 2004;12:505-512.
32. Liu X, Kohyama T, Kobayashi T, et al. Cigarette smoke extract inhibits chemotaxis and collagen gel contraction mediated by human bone marrow osteoprogenitor cells and osteoblast-like cells. Osteoporos Int. 2003;14:235-242.
33. Dejgaard A, Andersen T, Christoffersen P, et al. Plasma fibronectin concentrations in morbidly obese patients. Scand J Clin Lab Invest. 1984;44:207-210.
34. Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF->, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant. 1998;13:1476-1483.
35. Arita Y, Kihara S, Takahashi M, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
36. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002;147:173-180.
37. Abbasi F, Farin HM, Lamendola C, et al. The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J Clin Endocrinol Metab. 2006;91:5002-5007.
38. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem. 2004;50:1511-1525.
39. Saxena NK, Titus MA, Ding X, et al. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J. 2004;18:1612-1614.
40. Talukdar R, Saikia N, Singal DK, et al. Chronic pancreatitis: evolving paradigms. Pancreatology. 2006;6:440-449.